1997
DOI: 10.1542/peds.100.6.1004
|View full text |Cite
|
Sign up to set email alerts
|

Interventions for Perinatal Hypoxic–Ischemic Encephalopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
299
1
4

Year Published

1999
1999
2010
2010

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 446 publications
(307 citation statements)
references
References 149 publications
3
299
1
4
Order By: Relevance
“…Even when a successful therapy may allow the recovery of the affected patients as a requirement prior to therapy initiation, the hypoxic situation needs to be clearly and efficiently detected. Moreover, the time window between insult and start of therapy appears to be narrow (Vannucci andPerlman 1997, Roelfsema et al 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Even when a successful therapy may allow the recovery of the affected patients as a requirement prior to therapy initiation, the hypoxic situation needs to be clearly and efficiently detected. Moreover, the time window between insult and start of therapy appears to be narrow (Vannucci andPerlman 1997, Roelfsema et al 2004).…”
Section: Introductionmentioning
confidence: 99%
“…The need for early prediction of outcome is particularly important because of brief therapeutic window and possible side effects of neuroprotective interventions. 8 Based on animal studies and preliminary clinical experience, the therapeutic window in human neonates seems to be within 1 to 6 hours after birth. 9 Thus, it is important to look for useful predictors early in the course of disease, preferably within the first 6 hours after birth.…”
Section: Introductionmentioning
confidence: 99%
“…Multiple therapies that have shown promise in animal models include magnesium, inhibitory glutamate receptor antagonists, nitric oxide inhibitors, calcium channel blockers, platelet-activating factor antagonists, adenosinergic agents, growth factors, monosialoganglioside GM1, minocycline, xenon and erythropoietin. 11,18,[55][56][57][58][59] Despite initial promise shown in animal models, none of these therapies have shown utility in human trials. Whether therapeutic hypothermia functions synergistically with other therapies or provides an opportunity for these or other therapies to work is unknown.…”
Section: Therapeutic Hypothermiamentioning
confidence: 99%
“…16,17 It is this time during transition from the recovery period into the secondary phase of injury that allows for a potential window for neuroprotection or diminution of injury. 18 This therapeutic window of opportunity exists during the period of time following resuscitation of infants injured by hypoxic-ischemic insults but before the secondary phase of injury.…”
Section: Introductionmentioning
confidence: 99%